TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
MittVaccin Sverige AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,168
|
2,192
|
2,731 |
Financial expenses |
27
|
21
|
16 |
Earnings before taxes |
898
|
209
|
226 |
EBITDA |
1,112
|
416
|
438 |
Total assets |
3,572
|
2,575
|
1,461 |
Current assets |
3,554
|
2,371
|
1,036 |
Current liabilities |
1,377
|
1,320
|
363 |
Equity capital |
346
|
374
|
369 |
- share capital |
79
![]() |
79
|
86 |
Employees (average) |
7
![]() |
7
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
9.7%
|
14.5%
|
25.3% |
Turnover per employee |
453
|
313
|
546 |
Profit as a percentage of turnover |
28.3%
|
9.5%
|
8.3% |
Return on assets (ROA) |
25.9%
|
8.9%
|
16.6% |
Current ratio |
258.1%
|
179.6%
|
285.4% |
Return on equity (ROE) |
259.5%
|
55.9%
|
61.2% |
Change turnover |
970
|
-318
|
2,264 |
Change turnover % |
44%
|
-13%
|
485% |
Chg. No. of employees |
0
|
2
![]() |
2 |
Chg. No. of employees % |
0%
|
40%
|
67% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.